The HIV-1 Nef protein is essential for high-titer viral replication and AIDS progression. Nef functions by interacting with multiple host cell signaling proteins, including the members of the Src protein-tyrosine kinase family. Work completed during the previous grant period shows that Nef binds and activates Hck, Lyn, and c-Src, all of which are expressed in HIV target cells. This renewal application will test the overall hypothesis that these Src family members are important for Nef and HIV-1 function with the following Specific Aims:
Aim 1. Determine whether Hck, Lyn and c-Src are interchangeable in support of Net- dependent HIV-1 replication. RNAi and pharmacological approaches will be used to selectively suppress Hck, Lyn and c-Src activity in U87MG cells, followed by analysis of HIV infectivity and replication. Phosphoproteomics will be applied to identify signaling partners for Nef-Src family kinase complexes related to HIV replication. These experiments will address whether Hck, Lyn and c-Src serve unique or redundant functions in terms of Nef signaling and HIV replication.
Aim 2. Investigate the role of Nef oligomerization in Src family kinase activation, MHC and CD4 down-regulation, and HIV replication. We will map the Nef dimerization interface using a combination of molecular modeling, site-directed mutagenesis, and bimolecular fluorescence complementation (BiFC), which allows direct visualization of Nef:Nef interaction and subcellular localization in live cells. Oligomerization-defective Nef mutants will be tested for their ability to activate Src family kinases, induce MHC and CD4 down-regulation and support HIV infectivity and replication.
Aim 3. Determine whether Src family kinase activation and oligomerization are general properties of Nef alleles from a wide range of HIV-1 strains. Experiments in this Aim will address the generality of Nef-induced Src family kinase activation using Nef alleles representative of all major HIV-1 subgroups and a high-throughput yeast-based screen that faithfully models physiological Src family kinase regulation. We will also determine whether oligomerization is a general property of these HIV-1 Nef alleles using the BiFC approach described in Aim 2. Finally, we will test the hypothesis that primary Nef alleles from long-term non-progressors exhibit defects in oligomerization and/or Src family kinase activation. Systematic, large-scale analysis of Nef oligomerization and interactions with Src family kinases is an important prerequisite for future drug discovery efforts aimed at this Nef signaling pathway. Public Health Relevance: These studies are focused on a unique HIV-1 protein (Nef) that is essential for the progression of AIDS. Our work is focused on the interaction of Nef with protein kinases in infected cells. Completion of these experiments will validate these Nef-kinase complexes as targets for the discovery of new anti-HIV therapeutics. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA081398-08
Application #
7476429
Study Section
AIDS Molecular and Cellular Biology Study Section (AMCB)
Program Officer
Read-Connole, Elizabeth Lee
Project Start
1998-09-30
Project End
2011-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
8
Fiscal Year
2008
Total Cost
$223,256
Indirect Cost
Name
University of Pittsburgh
Department
Genetics
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Trible, Ronald P; Narute, Purushottam; Emert-Sedlak, Lori A et al. (2013) Discovery of a diaminoquinoxaline benzenesulfonamide antagonist of HIV-1 Nef function using a yeast-based phenotypic screen. Retrovirology 10:135
Engen, John R; Wales, Thomas E; Chen, Shugui et al. (2013) Partial cooperative unfolding in proteins as observed by hydrogen exchange mass spectrometry. Int Rev Phys Chem 32:96-127
Emert-Sedlak, Lori A; Narute, Purushottam; Shu, Sherry T et al. (2013) Effector kinase coupling enables high-throughput screens for direct HIV-1 Nef antagonists with antiretroviral activity. Chem Biol 20:82-91
Marcsisin, Sean R; Narute, Purushottam S; Emert-Sedlak, Lori A et al. (2011) On the solution conformation and dynamics of the HIV-1 viral infectivity factor. J Mol Biol 410:1008-22
de Groh, Eric D; Swanhart, Lisa M; Cosentino, Chiara Cianciolo et al. (2010) Inhibition of histone deacetylase expands the renal progenitor cell population. J Am Soc Nephrol 21:794-802
Dikeakos, Jimmy D; Atkins, Katelyn M; Thomas, Laurel et al. (2010) Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef action. Mol Biol Cell 21:3279-92
Schmaier, Alec A; Zou, Zhiying; Kazlauskas, Arunas et al. (2009) Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role. Proc Natl Acad Sci U S A 106:21167-72
Emert-Sedlak, Lori; Kodama, Toshiaki; Lerner, Edwina C et al. (2009) Chemical library screens targeting an HIV-1 accessory factor/host cell kinase complex identify novel antiretroviral compounds. ACS Chem Biol 4:939-47
Poe, Jerrod A; Smithgall, Thomas E (2009) HIV-1 Nef dimerization is required for Nef-mediated receptor downregulation and viral replication. J Mol Biol 394:329-42
Engen, J R; Wales, T E; Hochrein, J M et al. (2008) Structure and dynamic regulation of Src-family kinases. Cell Mol Life Sci 65:3058-73

Showing the most recent 10 out of 31 publications